Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

U.S. clinical trials on nonsurgical alternative to hysterectomy ahead of schedule

Sep. 27, 1996

Aldose reductase inhibitors from Dainippon

Sep. 27, 1996

Antihyperglycemic agents from Wyeth-Ayerst

Sep. 27, 1996

Takeda's pipeline of metabolic drugs

Sep. 27, 1996

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

Tularik-Japan Tobacco leptin gene collaboration

Sep. 27, 1996

Lilly's antiobesity proteins

Sep. 27, 1996

Hypocholesterolemic and hypocholesterolemic/antioxidant compounds from Pierre Fabre

Sep. 27, 1996

Takeda reports new agent for improving lipid metabolism

Sep. 27, 1996

Nippon Shoji's newest ACAT inhibitors

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...